Medical/Pharmaceuticals

Transcenta to Present Two Clinical Trial Progress at ASCO 2023

SUZHOU, China, May 8, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that two posters for c...

2023-05-08 14:55 2342

Bolivian and Taiwanese Experts Discuss the Latest Med-Tech Developments to Position Bolivia as a Leading hub in Robotic Neurosurgery

HSINCHU, May 8, 2023 /PRNewswire/ -- Medical experts from Bolivia and Taiwan recently joined forces to explore the latest technological advancements in surgical navigation robots and their potential to positionBolivia as a leader in robotic neurosurgery. During the largest robotic surgery online ...

2023-05-08 13:29 2552

EirGenix's Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives

TAIPEI, May 8, 2023 /PRNewswire/ -- EirGenix, Inc. (6589.TT) announced on 28th of April that it has completed the phase 1 clinical trial (EGC101) of its second breast cancer biosimilar EG1206A inEurope. Comparing EG1206A to Roche's Perjeta® US and EU, results of the clinical data analysis show th...

2023-05-08 10:00 2315

Innovent Announces First Participant Dosed in Phase 3 Study (RESTORE) of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Eye Disease

ROCKVILLE, MD. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2023-05-08 08:00 3626

Duoning Biotech Celebrates Ground Breaking for Its Global Headquarters

SHANGHAI, May 8, 2023 /PRNewswire/ -- On May 6th, the "2023 Commencement Ceremony for Major Industrial Projects in Fengxian and for Duoning's Global Headquarters and Industrialization Base" was held grandly in the Biotechnology Park. Leaders of the Fengxian district, representatives of the Orient...

2023-05-08 08:00 2629

Innovent Updates the Results from the ORIENT-31 Study of Sintilimab Plus Chemotherapy With or Without Bevacizumab in Patients with EGFR-TKI failed EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Lancet Respiratory Medicine

ROCKVILLE, Md. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2023-05-08 08:00 4194

World Lupus Federation Urges Global Community to Raise Lupus Awareness on May 10 for World Lupus Day 2023

Lupus awareness tools, facts and resources available at WorldLupusDay.org/tool-kit WASHINGTON, May 8, 2023 /PRNewswire/ -- World Lupus Day was established to take place onMay 10 by the World Lupus Federation (WLF) to unite lupus groups around the world during Lupus Awareness Month and call atten...

2023-05-08 08:00 2569

Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study

MELBOURNE, Australia, May 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injection)[1] for the Pha...

2023-05-08 05:00 5563

Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study, including Japanese Sites

MELBOURNE, Australia and KYOTO, Japan, May 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injectio...

2023-05-08 05:00 2535

Empowering Innovation to the Global Market with Acro Certify

TOKYO, May 6, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. It is an immense logistical and financial challenge that makes or breaks a company, despite the product itself. For companies in that awkward, transitional stage from start-up company to a m...

2023-05-06 10:18 4564

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey SHANGHAI, May 6, 2023 /PRNewswire/ -- CPHI & PMEC China will open in June (19-21st) at the Shanghai New International Expo Center as international audiences re...

2023-05-06 10:13 3483

Qiming Venture Partners Nisa Leung and Duane Kuang Made the 2023 Forbes Midas List

SHANGHAI, May 5, 2023 /PRNewswire/ -- The 2023 Forbes Midas List, a prestigious industry list of world's best venture capital investors, was unveiled. Qiming Venture Partners Managing Partner Nisa Leung and Founding Managing Partner Duane Kuang made the list. The Midas List, which was launched i...

2023-05-05 21:08 3753

New report by the Global Hygiene Council (GHC) highlights critical role of hygiene in the fight against antimicrobial resistance and future pandemics

LONDON, May 5, 2023 /PRNewswire/ -- A new report launched today by the Global Hygiene Council (GHC), an independent council of leading experts in hygiene and infection prevention, calls for urgent action to prioritise hygiene in home and community settings in pandemic preparedness plans beyond CO...

2023-05-05 20:14 3304

Viva Biotech's Recent Conferences & Events Review

HONG KONG, May 5, 2023 /PRNewswire/ -- In April, Viva Biotech was invited to attend 2022 SAPA-China Annual Conference, 88th API China, Drug Discovery Chemistry, American Association for Cancer Research (AACR) Annual Meeting 2023, CPHI Japan 2023, PharmFuture 2023 Small Molecule Innovative Drug Fu...

2023-05-05 19:58 4038

P&G Health commemorates Neuropathy Awareness Week 2023 with an effort to help people 'Put Life Back in Their Hands'

* Dons the purple ribbon for the 2nd consecutive year to raise awareness on Peripheral Neuropathy, a condition significantly underdiagnosed and undertreated inAsia, Middle East & Africa * Releases new research study highlighting the role of B Vitamins in supporting healthy nerve functions SIN...

2023-05-05 11:30 3744

Advanced Endoscopic Procedures: From Diagnosis to Minimally Invasive Treatments

SINGAPORE, May 5, 2023 /PRNewswire/ -- Endoscopy has come a long way since its inception in the mid-1800's. Various technological advancements within the realm of gastroenterology and hepatology have allowed the scope to reach deep-seated organs or examine long structures, like the intestines. "A...

2023-05-05 08:15 2591

MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA

GENEVA, May 5, 2023 /PRNewswire/ -- The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr.Arthur Lee at the Cardiac & Vascular Institute inFlorida. This study evaluates SELUTION SLR™ in the treatment of occlusive disease of the superficial femoral artery (SFA) and p...

2023-05-05 08:00 3340

SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

* SNIPR001 is a novel CRISPR-Cas therapeutic designed to selectively target antibiotic resistantE. coli, which can cause fatal infections in vulnerable hematological cancer patients             * SNIPR001 represents the first CRISPR- therapeutic developed to specifically removeE. coli in the ...

2023-05-05 00:52 2666

National Comprehensive Cancer Network Honors Cancer Leaders who Guide the Future of Care

Theresa J. Franco, Fred & Pamela Buffett Cancer Center; F. Marc Stewart, City of Hope National Medical Center;Douglas E. Wood, UW Medicine Fred Hutchinson Cancer Center; andDonna Powell, NCCN, presented with awards during NCCN 2023 Annual Conference. PLYMOUTH MEETING, Pa., May 4, 2023 /PRNewswir...

2023-05-04 23:00 2670

ANGUS ANNOUNCES CORPORATE REBRANDING, WILL CHANGE NAME TO "ADVANCION"

New name and brand reflect Company's strategic transformation into a leading global producer of specialty ingredients for Life Sciences, Personal Care and other essential markets BUFFALO GROVE, Ill., May 4, 2023 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company") today unveiled a new n...

2023-05-04 21:00 3614
1 ... 112113114115116117118 ... 397